+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Endometrial Ablation Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 160 Pages
  • September 2023
  • Region: Global
  • Expert Market Research
  • ID: 5895128
The endometrial ablation market value was USD 3.6 billion in 2023, driven by the increasing prevalence of abnormal uterine bleeding. The market size is anticipated to grow at a CAGR of 6% during the forecast period of 2024-2032 to achieve a value of USD 6.1 billion by 2032.

Endometrial Ablation: Introduction

Endometrial ablation is a medical procedure used to treat abnormal uterine bleeding by removing or destroying the lining of the uterus, called the endometrium. This procedure is primarily performed in women who experience heavy menstrual bleeding (menorrhagia) or irregular menstrual periods and have not responded to other conservative treatments like medication.

Endometrial ablation is not a contraceptive method, and women who undergo the procedure should continue to use contraception if they do not wish to become pregnant. Additionally, endometrial ablation is not recommended for women who plan to have more children in the future, as it can affect fertility. While endometrial ablation is an effective treatment for heavy menstrual bleeding, it is not suitable for everyone. The eligibility for this procedure depends on various factors, including the underlying cause of the bleeding, the patient's overall health, and their reproductive plans. Women considering endometrial ablation should discuss the risks, benefits, and alternatives with their healthcare provider to make an informed decision about the treatment.

Key Trends in the Endometrial Ablation Market

Here are some key trends in the market:

  • Rise in Minimally Invasive Procedures: Presently, there is a notable trend of increasing demand for minimally invasive gynecological procedures, including endometrial ablation. Patients and healthcare providers prefer these less invasive alternatives for managing abnormal uterine bleeding and other conditions.
  • Technological Advancements in Ablation Devices: Ongoing technological advancements have resulted in the development of more advanced and user-friendly endometrial ablation devices. These innovations are enhancing the precision, safety, and effectiveness of procedures.
  • Customized Treatment Approaches: There is currently an emphasis on personalized treatment approaches in the endometrial ablation market. Healthcare providers are tailoring ablation treatments to the specific needs and preferences of patients, improving patient satisfaction and outcomes.
  • Sustainability Initiatives: The market is witnessing growing awareness and implementation of sustainability initiatives. Manufacturers are focusing on eco-friendly materials and packaging to reduce the environmental impact of endometrial ablation products.
  • Telemedicine Integration: In line with the broader trend of telemedicine adoption, the endometrial ablation market is exploring ways to support remote consultations, pre-operative assessments, and follow-up care, making it more convenient for both patients and healthcare providers.

Endometrial Ablation Market Segmentations

The market can be categorized into type, indications, end user, and region.

Market Breakup by Type

Devices

  • Radiofrequency Ablation
  • Cryoablation
  • Microwave Ablation
  • Hydrothermal Ablation
  • Thermal Balloon Ablation
  • Laser Ablation
  • Electrical Ablation
  • Others
  • Procedures

Market by Indications

  • Abnormal Uterine Bleeding
  • Menorrhagia
  • Adenomyosis
  • Endometrial Hyperplasia

Market by End User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centres
  • Others

Market Breakup by Region - 7MM

  • United States
  • EU-4 and the United Kingdom
  • Japan

Endometrial Ablation Market Scenario

  • Market Growth: The endometrial ablation market is currently experiencing robust growth due to the increasing prevalence of abnormal uterine bleeding and the rising demand for minimally invasive treatment options. The market is expanding in both developed and emerging regions.
  • Women's Health and Wellbeing: Presently, there is a strong focus on women's health and wellbeing, leading to increased awareness of treatment options for conditions like heavy menstrual bleeding. Endometrial ablation procedures are gaining popularity as effective solutions.
  • COVID-19 Impact: The market scenario is influenced by the ongoing COVID-19 pandemic, with healthcare facilities adapting to ensure patient safety and reduce hospital stays. Minimally invasive endometrial ablation procedures have become even more relevant in this context.
  • Market Competitiveness: The endometrial ablation market remains competitive, with manufacturers continually innovating to gain a competitive edge. This competition drives product development and affordability.
  • Global Expansion: The market is expanding globally, with emerging regions showing increased interest in gynecological treatments and access to advanced medical technologies. This expansion contributes to market diversification.

Endometrial Ablation Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.

The major companies in the market are as follows:

  • AEGEA Medical, Inc.
  • Boston Scientific Corporation
  • CooperSurgical, Inc.
  • Hologic, Inc.
  • IDOMAN-MED
  • Minerva Surgical, Inc.
  • Olympus Corporation
  • Omnitech Systems, Inc.
  • Medtronic
The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Endometrial Ablation Market Overview
3.1 Endometrial Ablation Market Historical Value (2017-2023)
3.2 Endometrial Ablation Market Forecast Value (2024-2032)
4 Endometrial Ablation Market Landscape
4.1 Endometrial Ablation Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Endometrial Ablation Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Indications
5 Endometrial Ablation Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Endometrial Ablation Market Segmentation
6.1 Endometrial Ablation Market by Type
6.1.1 Market Overview
6.1.2 Devices
6.1.2.1 Radiofrequency Ablation
6.1.2.2 Cryoablation
6.1.2.3 Microwave Ablation
6.1.2.4 Hydrothermal Ablation
6.1.2.5 Thermal Balloon Ablation
6.1.2.6 Laser Ablation
6.1.2.7 Electrical Ablation
6.1.2.8 Others
6.1.3 Procedures
6.2 Endometrial Ablation Market by Indications
6.2.1 Market Overview
6.2.2 Abnormal Uterine Bleeding
6.2.3 Menorrhagia
6.2.4 Adenomyosis
6.2.5 Endometrial Hyperplasia
6.3 Endometrial Ablation Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Clinics
6.3.4 Ambulatory Surgical Centres
6.3.5 Others
6.4 Endometrial Ablation Market by Region - 7MM
6.4.1 Market Overview
6.4.2 United States
6.4.3 EU-4 and the United Kingdom
6.4.4 Japan
7 United States Endometrial Ablation Market
7.1 U.S. Endometrial Ablation Market Historical Size (2017-2023)
7.2 U.S. Endometrial Ablation Market Forecast Size (2024-2032)
7.3 Market Size by Therapeutic Class
8 EU-5 and the United Kingdom Endometrial Ablation Market
8.1 EU-5 and the United Kingdom Endometrial Ablation Market Historical Size (2017-2023)
8.2 EU-5 and the United Kingdom Endometrial Ablation Market Forecast Size (2024-2032)
8.3 Market Size by Therapeutic Class
9 Japan Endometrial Ablation Market
9.1 Japan Endometrial Ablation Market Historical Size (2017-2023)
9.2 Japan Endometrial Ablation Market Forecast Size (2024-2032)
9.3 Market Size by Therapeutic Class
10 Patent Analysis
10.1 Analysis by Type of Patent
10.2 Analysis by Publication year
10.3 Analysis by Issuing Authority
10.4 Analysis by Patent Age
10.5 Analysis by CPC Analysis
10.6 Analysis by Patent Valuation
10.7 Analysis by Key Players
11 Grants Analysis
11.1 Analysis by year
11.2 Analysis by Amount Awarded
11.3 Analysis by Issuing Authority
11.4 Analysis by Grant Application
11.5 Analysis by Funding Institute
11.6 Analysis by NIH Departments
11.7 Analysis by Recipient Organization
12 Funding Analysis
12.1 Analysis by Funding Instances
12.2 Analysis by Type of Funding
12.3 Analysis by Funding Amount
12.4 Analysis by Leading Players
12.5 Analysis by Leading Investors
12.6 Analysis by Geography
13 Partnership and Collaborations Analysis
13.1 Analysis by Partnership Instances
13.2 Analysis by Type of Partnership
13.3 Analysis by Leading Players
13.4 Analysis by Geography
14 Regulatory Framework
14.1 Regulatory Overview
14.1.1 US FDA
14.1.2 EU EMA
14.1.3 JAPAN PMDA
15 Supplier Landscape
15.1 AEGEA Medical, Inc.
15.1.1 Financial Analysis
15.1.2 Product Portfolio
15.1.3 Demographic Reach and Achievements
15.1.4 Mergers and Acquisition
15.1.5 Certifications
15.2 Boston Scientific Corporation
15.2.1 Financial Analysis
15.2.2 Product Portfolio
15.2.3 Demographic Reach and Achievements
15.2.4 Mergers and Acquisition
15.2.5 Certifications
15.3 CooperSurgical, Inc.
15.3.1 Financial Analysis
15.3.2 Product Portfolio
15.3.3 Demographic Reach and Achievements
15.3.4 Mergers and Acquisition
15.3.5 Certifications
15.4 Hologic, Inc.
15.4.1 Financial Analysis
15.4.2 Product Portfolio
15.4.3 Demographic Reach and Achievements
15.4.4 Mergers and Acquisition
15.4.5 Certifications
15.5 IDOMAN-MED
15.5.1 Financial Analysis
15.5.2 Product Portfolio
15.5.3 Demographic Reach and Achievements
15.5.4 Mergers and Acquisition
15.5.5 Certifications
15.6 Minerva Surgical, Inc.
15.6.1 Financial Analysis
15.6.2 Product Portfolio
15.6.3 Demographic Reach and Achievements
15.6.4 Mergers and Acquisition
15.6.5 Certifications
15.7 Olympus Corporation
15.7.1 Financial Analysis
15.7.2 Product Portfolio
15.7.3 Demographic Reach and Achievements
15.7.4 Mergers and Acquisition
15.7.5 Certifications
15.8 Omnitech Systems, Inc.
15.8.1 Financial Analysis
15.8.2 Product Portfolio
15.8.3 Demographic Reach and Achievements
15.8.4 Mergers and Acquisition
15.8.5 Certifications
15.9 Medtronic
15.9.1 Financial Analysis
15.9.2 Product Portfolio
15.9.3 Demographic Reach and Achievements
15.9.4 Mergers and Acquisition
15.9.5 Certifications
16 Endometrial Ablation Market - Distribution Model (Additional Insight)
16.1 Overview
16.2 Potential Distributors
16.3 Key Parameters for Distribution Partner Assessment
17 Key Opinion Leaders (KOL) Insights (Additional Insight)
18 Company Competitiveness Analysis (Additional Insight)
18.1 Very Small Companies
18.2 Small Companies
18.3 Mid-Sized Companies
18.4 Large Companies
18.5 Very Large Companies
19 Payment Methods (Additional Insight)
19.1 Government Funded
19.2 Private Insurance
19.3 Out-of-Pocket

Companies Mentioned

  • AEGEA Medical Inc.
  • Boston Scientific Corporation
  • CooperSurgical Inc.
  • Hologic Inc.
  • IDOMAN-MED
  • Minerva Surgical Inc.
  • Olympus Corporation
  • Omnitech Systems Inc.
  • Medtronic

Methodology

Loading
LOADING...